[
  {
    "criterion": "Provides a clear and actionable plan for prophylaxis despite limited data on qz-17.",
    "axis": "completeness",
    "point": 8
  },
  {
    "criterion": "Mentions that qz-17 is an emergent virus, but does not provide overly complicated medical information.",
    "axis": "communication_quality",
    "point": 5
  },
  {
    "criterion": "Correctly states that there are no established guidelines for qz-17 prophylaxis.",
    "axis": "accuracy",
    "point": 6
  },
  {
    "criterion": "Asks for additional background information on qz-17 transmission and patient risk factors.",
    "axis": "context_awareness",
    "point": 8
  },
  {
    "criterion": "Fails to provide a clear distinction between pharmacological and non-pharmacological prophylaxis options.",
    "axis": "accuracy",
    "point": -4
  },
  {
    "criterion": "Does not take into account the patient's age (27) when suggesting prophylaxis measures.",
    "axis": "context_awareness",
    "point": -2
  },
  {
    "criterion": "Provides a daily plan with recommended medications and measures, despite limited data on qz-17.",
    "axis": "completeness",
    "point": 9
  },
  {
    "criterion": "Uses technical language and jargon that may be difficult for non-medical professionals to understand.",
    "axis": "communication_quality",
    "point": -3
  },
  {
    "criterion": "Does not explicitly state that there is no robust evidence for qz-17 prophylaxis.",
    "axis": "completeness",
    "point": -1
  },
  {
    "criterion": "Asks for suspected or confirmed route of transmission, but does not provide a clear plan for prophylaxis.",
    "axis": "context_awareness",
    "point": 4
  },
  {
    "criterion": "Mentions that qz-17 was first identified in Mali last month, but does not provide additional information on the virus.",
    "axis": "completeness",
    "point": 2
  }
]